In trials, a vaccine for pancreatic cancer developed by Sloan-Ketterin and BioNTech showed promise, but researchers say it is ...
The phase 1 trial results, published Feb. 19 in Nature, evaluated the personalized mRNA neoantigen vaccine autogene cevumeran in combination with surgery, immunotherapy drug atezolizumab and ...
During a Case-Based Roundtable® event, Natalie Galanina, MD, discussed data from the ZUMA-7 and TRANSFORM trials in the first ...
Interesting Engineering on MSN4h
New mRNA vaccine shows promise against pancreatic cancer, may extend life by 10 yearsIn a significant development for pancreatic cancer treatment, a phase 1 clinical trial has highlighted the potential of personalized mRNA vaccines to treat the deadly disease. This research comes at a ...
AZoLifeSciences on MSN7h
Dysfunctional Memory B Cells Identified as Key Cancer Therapy TargetUniversity of Pittsburgh School of Medicine and UPMC Hillman Cancer Center scientists have discovered a novel subset of ...
A personalized mRNA vaccine may reduce the risks of pancreatic cancer returning after surgery, according to a preliminary ...
Immunotherapy is the form of treatment that redirects the immune system toward a pathogen or disease. In many cases, ...
Candel Therapeutics' lead candidate CAN-2409 shows promising results in several indications. Find out why I rate CADL stock ...
The integration of cytokines into stem cell and organoid research has significantly advanced drug discovery by enabling more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback